ArticleScience China. Life sciences2021

Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19.

Qiuyu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.